Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact…
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact…
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 30, 2023 (GLOBE…
Adi Elkeles CEO of Trobix Bio Netanya, Israel, March 30, 2023 – Trobix Bio, a…
ZUG, Switzerland and BOSTON, March 29, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
ZUG, Switzerland and BOSTON, March 29, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
– Founding CEO, Axel Bolte, MSc, MBA, to retire; Douglas A. Treco, Ph.D., to succeed…
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
The Company’s patent application describes how it plans to leverage cutting-edge CRISPR and mRNA technologies…
The Company’s patent application describes how it plans to leverage cutting-edge CRISPR and mRNA technologies…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Discovery of novel immune checkpoints in the tumor microenvironment with iOTarg™ screening platform Predictive biomarker…
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical…
ZUG, Switzerland and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
Linea Aspesi Linea Aspesi, Executive Vice President and Chief People Officer, Editas Medicine CAMBRIDGE, Mass.,…
EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation…
Reviews 2022 accomplishments; sets forth 2023 milestones and long-term vision LAWRENCEVILLE, N.J., March 01, 2023…